Skip to content
Home/Companies/Biotech/TR1X
TR

TR1X

Biotech·United States·Active·4yr hold

TR1X is a biotech company, headquartered in United States.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns TR1X?

TR1X is currently owned by Neva SGR through Neva First (2020 vintage), since 2022.

Hand-verified · updated 2026-07-23

Neva SGR
Investor
Neva SGR
Neva First · 2020 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Neva First

Other portfolio companies in the same fund.

AAVantgarde Bio
Active
BiotechItaly· 2025
BetaGlue
Active
MedTechItaly· 2024
NeoPhore
Active
BiotechUnited Kingdom· 2024
Caracol
Active
IndustrialsItaly· 2023
CoreTigo
Active
IndustrialsIsrael· 2023
Energy Dome
Active
EnergyItaly· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings